Cargando…
Trial Sequential Analysis and Updated Meta-Analysis of Fluvoxamine on Clinical Deterioration in Adult Patients with Symptomatic COVID-19 Infection
Preliminary meta-analyses suggested that fluvoxamine was effective in treating COVID-19 infection. However, the reliability of this evidence has not yet been examined. MEDLINE, CENTRAL, EMBASE, PsycINFO, and ClinicalTrials.gov were searched to identify any randomized controlled trials (RCTs) from th...
Autores principales: | Yu, Chia-Ling, Carvalho, Andre F., Thompson, Trevor, Tsai, Tzu-Cheng, Tseng, Ping-Tao, Hsu, Chih-Wei, Tu, Yu-Kang, Yang, Szu-Nian, Hsu, Tien-Wei, Yeh, Ta-Chuan, Liang, Chih-Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002389/ https://www.ncbi.nlm.nih.gov/pubmed/36901099 http://dx.doi.org/10.3390/ijerph20054088 |
Ejemplares similares
-
Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis
por: Yu, Chia-Ling, et al.
Publicado: (2021) -
Fluvoxamine for symptomatic outpatients with COVID-19
por: Wu, Peter E., et al.
Publicado: (2022) -
Early Fluvoxamine Reduces the Risk for Clinical Deterioration in Symptomatic Outpatients with COVID-19: A Real-World, Retrospective, before–after Analysis
por: Tsiakalos, Aristotelis, et al.
Publicado: (2023) -
Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis
por: Yu, Chia-Ling, et al.
Publicado: (2022) -
Correspondence on Fluvoxamine Treatment of Patients with Symptomatic COVID-19
por: Sookaromdee, Pathum, et al.
Publicado: (2022)